Advances allow for more accurate detection of metastatic disease.
Christopher J.D. Wallis, MD, PhD, FRCSC
Advertisement
Articles by Christopher J.D. Wallis, MD, PhD, FRCSC
Advances in receptor targeted PET imaging continue to refine the identification of metastatic disease.
Advertisement
Latest Updated Articles
Update on advanced imaging in prostate cancerPublished: June 11th 2021 | Updated:
Options increase for next-generation prostate cancer imagingPublished: September 10th 2020 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer
5
